Newsroom | 221828 results

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, has announced its expansion to any cart-based system with the launch of HeartFocus Link. Available now for medical schools, residency, and ultrasound training programs, HeartFocus Link addresses one of the most persistent barriers in cardiac ultrasound education and adoption: the challenge of helping healthcare professionals build confidence and competency using the...

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a global precision oncology company, today announced a new partnership with TOUCH, The Black Breast Cancer Alliance (TOUCH BBCA), a breast cancer patient advocacy organization, and Navigating Trials, a clinical trial navigation platform serving patients across all cancer types. Through this collaboration, Massive Bio's AI-powered trial matching will be made available directly within both organizations' digital platforms, giving their patient commu...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced that the company will present six posters at the 2026 Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research, sponsored by the family of former Notre Dame head football coach Ara Parseghian, taking place May 30 through June 2 in Tucson, Arizona. The posters...

SAN DIEGO--(BUSINESS WIRE)--Curebound Concert for Cures Series Surpasses $28M Raised for Cancer Research. 2026 Concert Features Electrifying Performance by P!NK at Petco Park....

TORONTO--(BUSINESS WIRE)--The union representing 2,500 health care workers at Scarborough Health Network is blaming the provincial government as the hospital battles a $36 million budget shortfall. Stacy James, president of CUPE 5852, says that SHN is facing a staffing crisis, which requires a big investment in improving conditions of work and care. However, the current budget deficit could lead to further reduction in staffing that would jeopardize the well-being of staff and patients alike. I...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its mission to build Multimodal Foundation Models at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus has been building novel biological foundation models and agentic workflows by leveraging its more than 500 petabytes of rich, molecularly grounded data—more than 45 million total de-identified...

SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading intelligence platform for clinical documentation and revenue integrity, today announced a significant expansion of chart-aware intelligence across its inpatient platform. Ambience previously introduced chart awareness, enabling AI to read and reason over a patient's full record rather than the conversation from a single encounter. With this expansion, chart-aware intelligence now covers every step of the hospital stay, from admiss...

TEL AVIV, Israel--(BUSINESS WIRE)--QuantHealth, the category leader in AI-driven clinical trial simulation, today announced the launch of its predictive competitive intelligence solution, an unprecedented capability designed to help life sciences organizations optimize not only for clinical trial success, but for future market leadership. By integrating clinical and commercial intelligence into R&D, the solution enables pharmaceutical and biotech organizations to make earlier and more infor...

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced $6 million in funding to support eight pioneering scientists advancing innovative ovarian cancer research across the United States. For more than a decade, the Foundation has advanced transformative cancer research through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Building on its longstanding commitment to cancer research and women’s health, the Foundation is now in the second year o...

TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) is pleased to report on the advancement of its patented Quicksome™ sublingual delivery platform as part of the Company’s strategy to position Quicksome™ as a differentiated delivery solution within the evolving compounded peptide marketplace across North and South America. Over the past six months, the Company has expanded its internal formulation capabilities following investments in l...